Hub : Traits :

Systolic blood pressure, automated reading

1513 significantly associated models · 378 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 752566 2544640 14 2 3.8e-11 2.0e-08 2.7e-01 96 TAS1R3 TMEM52
2 1 7715776 9571422 2 1 2.3e-11 9.3e-11 1.0e+00 100 RERE
3 1 10974329 12769239 7 4 2.0e-28 1.6e-39 1.5e-02 97 CLCN6
4 1 15314120 16760037 2 1 2.3e-08 8.5e-08 2.1e-02 82 PLEKHM2
5 1 43073464 44618031 7 1 1.0e-10 8.1e-11 1.0e+00 100 SZT2
6 1 59073430 60921087 1 1 7.2e-11 4.3e-15 7.3e-08 53 FGGY
7 1 66304567 67908644 1 1 2.1e-08 9.4e-09 1.2e-01 93 SGIP1
8 1 88453303 90145331 3 1 4.8e-11 8.0e-11 3.7e-02 90 GTF2B
9 1 112312154 114366434 4 3 3.3e-09 8.7e-15 6.0e-10 36 SLC16A1 WNT2B
10 1 183961643 185416670 1 1 7.9e-09 1.2e-06 9.1e-01 100 EDEM3
11 1 195927451 197414097 1 1 1.9e-07 8.5e-09 2.2e-04 59 CFH
12 1 209059239 210482140 1 1 1.8e-07 3.0e-08 6.3e-02 89 CAMK1G
13 1 230142626 231548480 1 1 1.7e-11 4.8e-12 9.5e-04 77 AGT
14 2 19492579 20908767 1 1 2.5e-08 7.7e-13 1.1e-06 54 MATN3
15 2 23453834 25692112 3 2 6.8e-10 1.6e-09 7.6e-02 91 NCOA1 UBXN2A
16 2 64586858 66008960 1 1 5.7e-13 1.7e-12 1.0e+00 100 CEP68
17 2 113686416 115095488 1 1 3.8e-08 3.0e-07 3.3e-01 96 RABL2A
18 2 134794256 136403272 3 1 2.1e-08 8.6e-08 2.8e-01 96 LOC100129961
19 2 158332890 160006143 1 1 2.8e-07 6.4e-09 2.1e-04 59 CCDC148
20 2 163760604 165290258 1 1 4.1e-07 3.1e-21 1.2e-15 28 FIGN
21 2 174238261 175812508 1 1 3.2e-07 2.3e-07 4.8e-02 85 OLA1
22 2 218421136 219878756 3 1 8.0e-09 9.3e-08 4.7e-07 11 TMBIM1
23 2 230499928 231967886 1 1 3.5e-07 1.1e-07 9.2e-02 90 SP140L
24 3 10617048 12457119 2 1 1.4e-09 8.0e-12 8.4e-04 76 VGLL4
25 3 26720690 28211713 1 1 3.0e-09 1.8e-08 5.2e-03 75 SLC4A7
26 3 40594264 42967174 2 1 1.2e-09 2.9e-09 3.2e-01 97 ULK4
27 3 47204518 50085153 9 2 3.2e-10 1.1e-08 3.8e-01 98 GPX1 NME6
28 3 52047421 53489090 1 1 3.0e-07 1.3e-06 1.4e-03 56 NEK4
29 3 65424578 67115640 1 1 3.9e-07 7.5e-06 2.3e-01 93 SLC25A26
30 3 123792729 125314016 1 1 1.6e-12 3.0e-11 6.9e-01 100 ITGB5
31 3 157125828 158980014 2 1 5.5e-08 6.4e-07 4.4e-01 98 RSRC1
32 3 159455723 160866230 1 1 1.7e-07 3.7e-07 2.5e-01 95 TRIM59
33 4 14310407 15767752 1 1 3.0e-07 2.9e-07 2.3e-02 80 CPEB2
34 4 17104059 18507692 1 1 4.4e-09 1.4e-08 8.1e-03 78 DCAF16
35 4 47802595 53472171 5 1 8.8e-13 5.1e-13 1.0e-01 95 OCIAD1
36 4 69893854 70983006 1 1 3.8e-07 7.0e-10 5.5e-05 57 RP11-790I12.2
37 4 80488345 82578407 2 1 4.1e-17 2.6e-41 6.5e-26 39 C4orf22
38 4 85698680 87621473 2 1 1.9e-18 3.4e-16 1.4e-01 97 ARHGAP24
39 4 145982563 147552337 1 1 8.2e-08 4.9e-09 1.6e-02 83 ZNF827
40 4 155890241 157354250 2 1 1.4e-13 2.5e-13 2.4e-03 83 RP11-588K22.2
41 5 70709459 72201058 1 2 4.4e-08 1.7e-06 8.2e-01 100 MAP1B
42 5 121488203 123054717 1 1 1.3e-09 4.6e-14 4.0e-07 55 SNX24
43 5 126587995 128118088 1 1 9.2e-08 8.5e-13 1.5e-08 37 FLJ33630
44 6 12595275 13990267 1 1 1.1e-07 3.6e-08 7.7e-02 90 RP1-257A7.5
45 6 25285943 26689223 1 1 6.2e-08 2.0e-09 3.0e-04 64 U91328.21
46 6 55222696 56954550 1 2 1.9e-08 7.1e-08 1.0e+00 100 COL21A1
47 6 78880271 80486611 2 1 8.8e-09 1.6e-08 1.0e+00 100 IRAK1BP1
48 6 96275538 97756290 2 1 1.5e-10 2.8e-12 4.5e-03 84 UFL1
49 6 117078784 118726243 3 1 1.4e-14 3.6e-10 7.8e-02 92 GOPC
50 6 126271503 128536730 2 1 3.5e-09 9.5e-20 4.4e-12 42 PRELID1P1
51 6 146826657 148410391 2 1 1.1e-08 1.5e-08 9.5e-02 91 STXBP5
52 7 23913624 25432157 1 1 1.6e-08 6.9e-09 1.0e+00 100 MPP6
53 7 74339397 76209459 6 1 1.6e-07 2.7e-07 1.0e+00 100 PMS2P3
54 7 90737969 93160671 6 5 1.2e-14 2.9e-15 1.0e+00 100 CDK6 GATAD1 KRIT1 MTERF
55 7 130307434 131708281 1 1 7.8e-11 9.5e-13 1.0e-04 70 MKLN1-AS2
56 8 8092025 13120332 26 3 4.5e-14 1.4e-15 2.6e-03 86 FDFT1 MSRA NEIL2
57 8 21600469 23096594 1 1 2.2e-07 1.2e-06 1.0e+00 100 PPP3CC
58 8 119737284 121136001 1 1 1.3e-11 7.5e-10 3.3e-02 88 NOV
59 9 33414173 35019603 2 2 9.5e-09 2.6e-07 5.9e-02 86 DCAF12 KIF24
60 10 11693166 13569805 1 1 1.4e-07 1.1e-07 9.0e-02 90 CAMK1D
61 10 18221643 19637020 2 1 1.7e-11 2.7e-21 1.5e-16 24 NSUN6
62 10 63856856 65606229 3 1 3.8e-13 3.3e-13 5.3e-02 93 RP11-436D10.3
63 10 68861272 70358745 2 1 5.2e-09 9.9e-09 3.5e-02 86 DNAJC12
64 10 74714177 77160682 8 1 5.9e-15 1.6e-11 1.1e-01 94 FUT11
65 10 95379543 97524313 4 2 4.4e-11 1.3e-17 7.6e-06 73 NOC3L TBC1D12
66 10 103313599 106371784 15 10 9.9e-25 1.4e-28 1.0e+00 100 ARL3 CNNM2 CYP17A1-AS1 INA NT5C2 RP11-541N10.3 SFXN2
67 11 1213806 2705175 3 1 4.2e-20 7.9e-23 1.4e-10 57 TNNT3
68 11 7949791 11027552 3 3 1.6e-12 5.8e-16 1.1e-02 90 ADM SWAP70 TRIM66
69 11 16709350 18095815 1 1 5.2e-08 1.0e-06 6.4e-01 99 RP1-239B22.5
70 11 46033104 48783497 15 1 3.0e-13 1.3e-13 6.6e-04 79 FNBP4
71 11 56774260 58178587 1 1 6.5e-11 4.5e-08 6.3e-02 88 MED19
72 11 62922117 64374241 1 1 1.6e-07 4.4e-06 7.7e-02 85 MARK2
73 11 64948277 66333072 2 1 3.3e-08 1.3e-07 6.2e-02 88 FIBP
74 11 99859184 101559718 2 1 3.5e-39 1.6e-34 9.7e-01 100 TMEM133
75 11 106485489 108027561 2 1 1.9e-14 1.2e-17 5.1e-05 78 CWF19L2
76 11 112440560 113841003 1 1 4.5e-08 1.2e-10 2.8e-05 58 NCAM1-AS1
77 11 129575976 130992111 1 1 2.8e-07 1.2e-15 1.5e-10 36 ADAMTS8
78 12 26425752 27828938 1 1 7.4e-08 5.1e-07 8.6e-06 22 RP11-421F16.3
79 12 49356534 51256065 5 2 3.1e-10 2.4e-09 1.0e+00 100 AQP5 CERS5
80 12 89116708 90799212 3 1 1.0e-21 8.5e-30 1.1e-09 71 ATP2B1
81 12 109670468 113517494 15 2 8.9e-21 2.5e-18 8.2e-04 85 GIT2 SH2B3
82 13 114302502 115106996 2 1 1.8e-08 4.2e-08 2.5e-01 96 UPF3A
83 14 22670975 24147787 4 2 2.0e-11 6.1e-11 2.7e-08 28 HAUS4 RBM23
84 14 99506342 101101120 1 1 2.0e-09 3.4e-07 7.3e-01 100 EML1
85 15 39530508 42749023 12 2 8.3e-13 9.5e-12 1.9e-03 79 EIF2AK4 GCHFR
86 15 62639641 64123980 2 1 6.6e-09 2.6e-08 3.7e-01 97 LACTB
87 15 74042497 76108550 9 1 1.1e-14 4.5e-15 6.5e-02 94 UBL7
88 15 80272818 81936479 2 2 2.1e-14 4.2e-15 7.9e-02 95 ABHD17C KIAA1199
89 15 90373873 92135418 3 1 5.0e-31 2.5e-27 3.9e-01 99 FES
90 16 1381714 2713729 1 1 9.3e-09 3.7e-09 1.3e-01 93 SLC9A3R2
91 16 3025993 5593819 4 3 2.6e-08 2.2e-09 7.0e-09 6 AC006111.1 GLYR1 MGRN1
92 16 24042724 25620010 2 1 5.1e-15 7.8e-15 1.0e+00 100 SLC5A11
93 16 69292222 72020323 8 2 9.7e-09 2.6e-07 1.2e-01 91 CMTR2 RP11-296I10.6
94 16 74578110 76197034 3 1 2.3e-12 4.0e-13 1.0e+00 100 CFDP1
95 17 554080 3011213 5 2 3.4e-14 8.1e-14 7.2e-04 80 CRK SRR
96 17 6285368 8173767 9 3 5.6e-11 5.2e-10 2.4e-01 96 CLEC10A SENP3 SLC2A4
97 17 42317371 47688526 43 17 8.1e-21 1.1e-19 NaN NaN ARL17A ARL17B CBX1 DCAKD FMNL1 HOXB2 HOXB8 ITGB3 LRRC37A4P RP11-6N17.4 RP11-6N17.6 SNX11
98 17 57276710 58660283 1 1 9.3e-08 5.8e-08 1.1e-06 20 RPS6KB1
99 17 58828402 60172573 2 1 1.1e-10 2.3e-10 7.8e-02 92 RP11-332H18.4
100 17 61527677 62983145 1 1 1.8e-11 1.1e-09 1.7e-01 95 TEX2
101 17 75977988 77462467 2 1 2.3e-09 2.6e-10 1.0e+00 100 USP36
102 19 1086043 2923263 3 2 9.9e-09 8.5e-09 1.0e+00 100 ATP8B3 PLEKHJ1
103 19 9637688 11035604 1 1 3.2e-07 1.6e-09 1.7e-04 61 S1PR2
104 19 45585167 46967227 1 1 1.3e-07 1.5e-06 7.0e-01 99 AC074212.6
105 20 61522825 62912463 7 3 7.3e-13 2.3e-10 2.8e-02 88 LIME1 TCEA2 ZBTB46

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Crohns Disease (2017) 1.53 3 2 6.1 0.00 1.0e+00 GPX1 RP11-436D10.3 TMBIM1
Irritable Bowel Disease (IBD) 1.56 5 3 9.1 0.15 8.1e-01 GPX1 RP11-436D10.3 TMBIM1 TMEM52 USP36
Ulcerative Colitis (UC) 1.39 2 1 3.0 0.00 1.0e+00 GPX1 TMBIM1
Major Depression (MDD) 1.83 4 0 0.0 -0.47 5.3e-01 CNNM2 FES GPX1 NT5C2
Reaction Time 1.92 5 4 12.1 0.28 6.5e-01 ARL17A ARL17B CAMK1G OLA1 SH2B3
Verbal and Numeric Reasoning (VNR) 1.41 6 2 6.1 0.40 4.4e-01 ARL17B CYP17A1-AS1 DCAF16 GPX1 NEK4 SLC5A11
Breast Cancer 2.02 8 4 12.1 -0.31 4.1e-01 ARL17B FES FIBP KRIT1 LRRC37A4P RP11-436D10.3 SLC4A7 TNNT3
Ovarian Cancer 1.75 3 1 3.0 0.09 9.1e-01 HOXB2 LRRC37A4P SNX11
Prostate Cancer 1.42 1 0 0.0 0.00 1.0e+00 GPX1
Age at First Birth 1.49 1 1 3.0 0.00 1.0e+00 GPX1
Bipolar Disorder 1.77 1 0 0.0 0.00 1.0e+00 NEK4
Body Mass Index (BMI) (2010) 1.67 1 0 0.0 0.00 1.0e+00 PMS2P3
Coronary Artery Disease (CAD) 2.73 2 1 3.0 0.00 1.0e+00 CNNM2 RP1-257A7.5
Crohns Disease (2012) 1.58 1 0 0.0 0.00 1.0e+00 RP11-436D10.3
Fasting Glucose 1.40 1 0 0.0 0.00 1.0e+00 FNBP4
HDL Cholesterol 1.05 1 0 0.0 0.00 1.0e+00 LACTB
LDL Cholesterol 1.24 1 0 0.0 0.00 1.0e+00 SH2B3
Lupus 1.61 3 1 3.0 0.00 1.0e+00 FDFT1 MSRA PLEKHJ1
Neuroticism 2.29 7 3 9.1 0.60 1.2e-01 ADM ARL17B FDFT1 FMNL1 GPX1 LRRC37A4P MSRA
Primary Biliary Cirrhosis 1.42 4 2 6.1 -0.99 1.2e-03 FMNL1 LRRC37A4P SH2B3 TRIM59
Rheumatoid Arthritis 1.32 2 0 0.0 0.00 1.0e+00 CDK6 SH2B3
Schizophrenia 2.16 10 6 18.2 -0.53 9.1e-02 ARL3 CERS5 CNNM2 CYP17A1-AS1 FES MARK2 MSRA NEK4 NT5C2 RERE
Triglycerides 1.12 2 0 0.0 0.00 1.0e+00 FDFT1 MSRA
Ulcerative Colitis 1.35 2 1 3.0 0.00 1.0e+00 GPX1 TMBIM1
Blood Eosinophil Count 2.31 20 13 39.4 -0.25 2.5e-01 AC074212.6 ARL17B CDK6 CERS5 DCAKD FIBP FMNL1 FUT11 GATAD1 GIT2 GPX1 HAUS4 KRIT1 LRRC37A4P MED19 NEK4 RERE SH2B3 SLC2A4 UPF3A
Blood Platelet Count 1.48 43 28 84.8 -0.48 9.6e-04 AC074212.6 ARHGAP24 ARL17A ARL3 CDK6 CERS5 CFDP1 CLCN6 CLEC10A CMTR2 CRK CWF19L2 CYP17A1-AS1 DCAF16 DCAKD DNAJC12 EDEM3 FIBP FNBP4 FUT11 GATAD1 GIT2 GTF2B IRAK1BP1 KRIT1 LACTB LIME1 MGRN1 MPP6 MTERF NEK4 OCIAD1 RP11-436D10.3 RP1-239B22.5 RPS6KB1 SH2B3 SLC4A7 STXBP5 SZT2 TBC1D12 TMBIM1 TRIM66 WNT2B
Blood Red Count 2.22 36 26 78.8 0.06 7.3e-01 ADM ARL17B ARL3 C4orf22 CLCN6 CNNM2 CRK DCAKD EIF2AK4 FLJ33630 FMNL1 GATAD1 GCHFR GTF2B KRIT1 LOC100129961 LRRC37A4P MGRN1 MTERF NEK4 NME6 NOV NT5C2 RP11-332H18.4 RP11-541N10.3 RP1-257A7.5 RPS6KB1 SH2B3 SLC9A3R2 SNX11 SZT2 TBC1D12 TRIM66 UBL7 ULK4 USP36
Blood White Count 2.10 34 20 60.6 -0.32 5.3e-02 ARHGAP24 ARL3 CDK6 CERS5 CRK DCAF16 DNAJC12 FES FIBP FMNL1 GATAD1 GLYR1 GPX1 GTF2B HOXB8 INA LRRC37A4P MGRN1 NCOA1 NME6 NT5C2 RERE RP11-6N17.6 RPS6KB1 S1PR2 SH2B3 SLC5A11 SLC9A3R2 SNX11 SZT2 TBC1D12 TMBIM1 TMEM133 TRIM66
Heel T-Score 2.37 40 30 90.9 -0.29 4.7e-02 ARHGAP24 ARL17A ARL17B ARL3 CDK6 CNNM2 COL21A1 CPEB2 DCAF16 DCAKD FIBP FMNL1 FNBP4 GATAD1 GTF2B INA KRIT1 LACTB LRRC37A4P MAP1B MTERF NME6 NOV NT5C2 PLEKHM2 RERE RP11-6N17.6 SENP3 SGIP1 SLC2A4 SLC5A11 SLC9A3R2 SNX11 SRR TMBIM1 TMEM133 TRIM59 VGLL4 WNT2B ZNF827
BMI 1.84 32 21 63.6 -0.19 2.9e-01 ARL3 ATP8B3 C4orf22 CBX1 CNNM2 CYP17A1-AS1 DCAF12 EDEM3 FIBP GPX1 HOXB8 KIAA1199 KIF24 LOC100129961 NCOA1 NEK4 NT5C2 OLA1 PLEKHM2 PMS2P3 RP11-296I10.6 RP11-6N17.4 RP1-239B22.5 RSRC1 SLC5A11 SLC9A3R2 SNX11 SRR STXBP5 TMEM52 USP36 VGLL4
Height 2.96 71 62 187.9 0.47 1.4e-05 AC074212.6 ADM ARHGAP24 ARL17A ARL17B CDK6 CERS5 CFDP1 CLEC10A CMTR2 CRK CYP17A1-AS1 DCAF12 DCAF16 DCAKD EDEM3 FES FGGY FLJ33630 GATAD1 GCHFR GLYR1 GOPC GPX1 GTF2B HOXB2 HOXB8 KIF24 KRIT1 LRRC37A4P MED19 MGRN1 MKLN1-AS2 MPP6 MTERF NCOA1 NEK4 NME6 NOV OCIAD1 PMS2P3 PRELID1P1 RABL2A RERE RP11-296I10.6 RP11-332H18.4 RP11-436D10.3 RP11-6N17.6 RP1-239B22.5 RSRC1 S1PR2 SENP3 SFXN2 SH2B3 SLC16A1 SLC4A7 SLC5A11 SLC9A3R2 SNX11 SZT2 TBC1D12 TEX2 TMBIM1 TMEM133 TNNT3 TRIM66 UBXN2A UPF3A USP36 WNT2B ZNF827
Waist Hip Ratio (WHR) 1.54 14 9 27.3 0.11 7.0e-01 ADM FNBP4 GPX1 LRRC37A4P MARK2 NCOA1 NEK4 PRELID1P1 RP11-332H18.4 RP1-239B22.5 SWAP70 TCEA2 TMBIM1 UBXN2A
Systolic Blood Pressure 14.40 143 132 400.0 -0.98 3.2e-120 ABHD17C AC006111.1 AC074212.6 ADAMTS8 ADM AGT AQP5 ARHGAP24 ARL17A ARL17B ARL3 ATP2B1 ATP8B3 C4orf22 CAMK1D CAMK1G CBX1 CCDC148 CDK6 CEP68 CERS5 CFDP1 CFH CLCN6 CLEC10A CMTR2 CNNM2 COL21A1 CPEB2 CRK CWF19L2 CYP17A1-AS1 DCAF12 DCAF16 DCAKD DNAJC12 EDEM3 EIF2AK4 EML1 FES FGGY FIBP FIGN FLJ33630 FMNL1 FNBP4 FUT11 GATAD1 GCHFR GIT2 GLYR1 GOPC GPX1 GTF2B HAUS4 HOXB2 HOXB8 INA IRAK1BP1 ITGB3 ITGB5 KIAA1199 KIF24 KRIT1 LACTB LIME1 LOC100129961 LRRC37A4P MAP1B MARK2 MATN3 MED19 MGRN1 MKLN1-AS2 MPP6 MTERF NCOA1 NEK4 NME6 NOC3L NOV NSUN6 NT5C2 OCIAD1 OLA1 PLEKHJ1 PLEKHM2 PMS2P3 PPP3CC PRELID1P1 RABL2A RBM23 RERE RP11-296I10.6 RP11-332H18.4 RP11-421F16.3 RP11-436D10.3 RP11-541N10.3 RP11-588K22.2 RP11-6N17.4 RP11-6N17.6 RP11-790I12.2 RP1-239B22.5 RP1-257A7.5 RPS6KB1 RSRC1 S1PR2 SENP3 SFXN2 SGIP1 SH2B3 SLC16A1 SLC25A26 SLC2A4 SLC4A7 SLC5A11 SLC9A3R2 SNX11 SNX24 SP140L SRR STXBP5 SWAP70 SZT2 TAS1R3 TBC1D12 TCEA2 TEX2 TMBIM1 TMEM133 TMEM52 TNNT3 TRIM59 UBL7 UBXN2A UFL1 ULK4 UPF3A USP36 VGLL4 WNT2B ZBTB46 ZNF827
Smoking Status 1.76 12 7 21.2 -0.20 5.3e-01 ARL3 CYP17A1-AS1 FES GPX1 INA KIAA1199 NCAM1-AS1 NEK4 NT5C2 RERE SLC5A11 SRR
Allergy or Eczema 1.44 9 2 6.1 -0.54 1.3e-01 ARL3 CFDP1 CLCN6 CYP17A1-AS1 GCHFR LIME1 PLEKHM2 RERE TMBIM1
Cardiovascular Disease 7.37 75 51 154.5 -0.98 1.3e-57 AC006111.1 AGT AQP5 ARHGAP24 ARL17A ARL3 ATP2B1 ATP8B3 C4orf22 CCDC148 CDK6 CEP68 CERS5 CFDP1 CLCN6 CMTR2 CNNM2 CPEB2 CRK CWF19L2 DCAF16 DCAKD FES FIBP FLJ33630 FNBP4 FUT11 GATAD1 GCHFR GIT2 GLYR1 GOPC GTF2B HOXB2 HOXB8 IRAK1BP1 ITGB3 ITGB5 KIAA1199 LIME1 MKLN1-AS2 NME6 NOC3L NSUN6 NT5C2 OLA1 PLEKHM2 PMS2P3 PRELID1P1 RP11-296I10.6 RP11-332H18.4 RP11-436D10.3 RP11-588K22.2 RP1-239B22.5 SENP3 SFXN2 SGIP1 SH2B3 SLC2A4 SLC4A7 SWAP70 TBC1D12 TCEA2 TEX2 TMBIM1 TMEM133 TNNT3 TRIM59 UBL7 UFL1 UPF3A USP36 VGLL4 WNT2B ZBTB46
Hypothyroidism (self reported) 1.64 2 1 3.0 0.00 1.0e+00 RERE SH2B3
Respiratory disease 1.15 4 1 3.0 -0.59 4.1e-01 AC074212.6 DCAKD RERE UFL1
Type 2 Diabetes (T2D) 2.10 5 3 9.1 -0.63 2.6e-01 CAMK1D PRELID1P1 RP1-239B22.5 SH2B3 ZBTB46
Lung FEV1/FVC ratio 2.07 20 14 42.4 0.23 3.1e-01 AC074212.6 ADM ATP2B1 ATP8B3 CAMK1D CFDP1 GOPC HAUS4 KIF24 LRRC37A4P NEK4 NOV RERE RP11-436D10.3 RP11-6N17.6 S1PR2 SNX11 TMEM133 ULK4 VGLL4
Lung FVC 2.44 26 19 57.6 0.09 6.7e-01 ADAMTS8 ARL17A ARL17B CAMK1D COL21A1 CRK DCAF16 FLJ33630 FMNL1 GCHFR GIT2 GPX1 HOXB2 LOC100129961 LRRC37A4P NOV RP11-332H18.4 RP11-541N10.3 RSRC1 SNX11 TCEA2 TMEM52 UBXN2A USP36 WNT2B ZBTB46
Neuroticism 2.32 9 6 18.2 -0.04 9.0e-01 ADM ARL17B CNNM2 CYP17A1-AS1 FMNL1 GPX1 LRRC37A4P NT5C2 RERE
Chronotype (morning person) 1.19 2 0 0.0 0.00 1.0e+00 ARL3 DCAF12
Hair Pigment 0.44 14 12 36.4 -0.11 6.5e-01 ADM ARL17A ATP2B1 C4orf22 CBX1 FES GCHFR HOXB2 HOXB8 LOC100129961 MTERF RP11-6N17.6 SH2B3 SNX11
Tanning 0.29 6 2 6.1 0.21 6.0e-01 CYP17A1-AS1 NEK4 RP11-436D10.3 RP11-6N17.6 SH2B3 SNX11
Hand grip strength (left) 2.01 14 8 24.2 -0.25 3.4e-01 ARL17B CLEC10A CYP17A1-AS1 DCAF16 FES HOXB2 LOC100129961 LRRC37A4P NCOA1 RP1-257A7.5 SFXN2 SLC5A11 SLC9A3R2 SNX11
Number of treatments/medications taken 2.47 6 3 9.1 0.96 2.4e-03 DCAF16 GPX1 KIAA1199 SH2B3 TEX2 TMEM133
Sensitivity / hurt feelings 2.30 8 3 9.1 -0.94 1.6e-04 ARL17B DCAKD FDFT1 FES FMNL1 LRRC37A4P MSRA U91328.21
Frequency of depressed mood in last 2 weeks 1.31 1 0 0.0 0.00 1.0e+00 ARL17B
Hearing difficulty/problems: Yes 1.14 1 0 0.0 0.00 1.0e+00 FUT11
Relative age of first facial hair 2.36 7 6 18.2 -0.55 1.6e-01 ARL17B C4orf22 DCAKD FMNL1 LRRC37A4P MKLN1-AS2 VGLL4
Angina 2.23 3 1 3.0 0.00 1.0e+00 FES RP1-257A7.5 TCEA2
Medication: Metformin 1.84 1 1 3.0 0.00 1.0e+00 CAMK1D
Diabetes (mother) 1.83 3 1 3.0 -0.43 4.7e-01 CAMK1D RP11-6N17.6 SNX11
Pack years adult smoking proportion 1.18 1 0 0.0 0.00 1.0e+00 GPX1
Impedance of leg (right) 2.10 28 19 57.6 0.26 1.7e-01 ADM ARL3 CDK6 CERS5 CNNM2 DCAF12 DCAKD FDFT1 FES FLJ33630 FMNL1 GPX1 KIAA1199 KIF24 LRRC37A4P MSRA NEK4 NOC3L NT5C2 PMS2P3 RP11-296I10.6 RP1-239B22.5 RPS6KB1 SWAP70 TBC1D12 TMEM133 TMEM52 WNT2B
Leg fat-free mass (left) 2.38 34 19 57.6 -0.49 1.7e-03 ADM ARHGAP24 ARL3 CBX1 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FDFT1 FIBP FLJ33630 GATAD1 GLYR1 KIAA1199 KRIT1 MSRA MTERF NCOA1 NOV NT5C2 PMS2P3 PRELID1P1 RP11-332H18.4 RP11-436D10.3 RP11-6N17.4 S1PR2 SFXN2 SLC5A11 SLC9A3R2 SNX11 TMEM52 UPF3A USP36
Trunk fat percentage 2.13 28 15 45.5 0.65 1.4e-04 ABHD17C ADM ARL17A ARL17B CCDC148 DCAKD EDEM3 FMNL1 FNBP4 GPX1 LOC100129961 LRRC37A4P MPP6 NOC3L OCIAD1 OLA1 PMS2P3 RERE RP11-296I10.6 RP11-6N17.4 SENP3 SLC5A11 SLC9A3R2 SNX11 SRR TBC1D12 UPF3A WNT2B
Hand grip strength (right) 1.94 11 8 24.2 -0.04 9.0e-01 ARL17B CYP17A1-AS1 DCAF16 EDEM3 LOC100129961 LRRC37A4P NCOA1 SFXN2 SLC5A11 SLC9A3R2 SNX11
Townsend deprivation index at recruitment 1.16 1 0 0.0 0.00 1.0e+00 SGIP1
Current tobacco smoking 1.54 2 0 0.0 0.00 1.0e+00 MSRA SLC5A11
Average weekly fortified wine intake 1.03 1 0 0.0 0.00 1.0e+00 SLC5A11
Maternal smoking around birth 1.51 1 0 0.0 0.00 1.0e+00 SLC5A11
Fed-up feelings 1.77 7 5 15.2 -0.63 9.1e-02 ARL17B FDFT1 FMNL1 GPX1 LRRC37A4P MSRA SH2B3
Relative age voice broke 1.79 3 2 6.1 -0.65 3.5e-01 ARL17B FMNL1 LRRC37A4P
Taking other prescription medications 1.34 2 1 3.0 0.00 1.0e+00 GPX1 SH2B3
Age when periods started (menarche) 1.47 7 2 6.1 -0.42 3.5e-01 DCAKD GPX1 LRRC37A4P NEK4 PMS2P3 STXBP5 SZT2
Heel bone mineral density (BMD) T-score, automated (left) 2.14 8 7 21.2 0.77 1.4e-02 ARHGAP24 CDK6 FDFT1 GATAD1 MSRA RERE WNT2B ZNF827
High blood pressure 8.19 81 44 133.3 0.98 5.2e-60 AC006111.1 ADM AGT AQP5 ARHGAP24 ARL17A ARL3 ATP2B1 ATP8B3 C4orf22 CCDC148 CERS5 CFDP1 CLCN6 CLEC10A CNNM2 CWF19L2 DCAF12 DCAF16 DCAKD EDEM3 FDFT1 FES FIBP FLJ33630 FMNL1 FNBP4 GCHFR GIT2 GLYR1 GOPC GTF2B HOXB2 HOXB8 IRAK1BP1 ITGB5 KIAA1199 LIME1 LRRC37A4P MARK2 MGRN1 MSRA NCOA1 NEIL2 NME6 NOC3L NSUN6 NT5C2 PLEKHJ1 PLEKHM2 PMS2P3 PRELID1P1 RP11-296I10.6 RP11-332H18.4 RP11-436D10.3 RP11-588K22.2 RP11-790I12.2 RP1-239B22.5 RSRC1 S1PR2 SENP3 SFXN2 SGIP1 SH2B3 SLC2A4 SLC4A7 SLC5A11 SRR SWAP70 SZT2 TBC1D12 TCEA2 TMEM133 TNNT3 U91328.21 UBL7 UFL1 UPF3A VGLL4 WNT2B ZBTB46
Hayfever, allergic rhinitis or eczema 1.30 2 1 3.0 0.00 1.0e+00 GCHFR RERE
Medication: Atenolol 3.05 3 2 6.1 0.00 1.0e+00 FES SH2B3 TMEM133
Medication: Levothyroxine sodium 1.57 2 1 3.0 0.00 1.0e+00 MSRA SH2B3
Sitting height 2.27 31 21 63.6 -0.24 1.7e-01 AC074212.6 ADM ARL17B CDK6 CERS5 CYP17A1-AS1 DCAF16 GATAD1 GLYR1 GOPC GTF2B HOXB8 KIAA1199 KRIT1 LRRC37A4P MTERF NCOA1 NOV PRELID1P1 RP11-436D10.3 RSRC1 S1PR2 SLC4A7 SLC9A3R2 SZT2 TAS1R3 TBC1D12 TMBIM1 UBXN2A UPF3A VGLL4
High blood pressure (mother) 3.87 9 2 6.1 0.97 1.5e-05 AGT CFDP1 CLCN6 CLEC10A CNNM2 FES ITGB5 SLC4A7 TNNT3
Body mass index (BMI) 1.89 22 11 33.3 0.58 4.9e-03 ARL3 CCDC148 CNNM2 DCAF12 EDEM3 FDFT1 FIBP GPX1 HOXB8 KIAA1199 LOC100129961 MPP6 MSRA NCOA1 NEK4 OLA1 PMS2P3 RP11-296I10.6 RP11-6N17.4 SLC5A11 SLC9A3R2 TMEM52
Impedance of leg (left) 2.16 28 20 60.6 0.25 1.8e-01 ADM ARL3 CDK6 CERS5 CNNM2 DCAF12 DCAKD FDFT1 FES FLJ33630 FMNL1 GPX1 KIAA1199 KIF24 LRRC37A4P MSRA NEK4 NOC3L NT5C2 PMS2P3 RP11-296I10.6 RP1-239B22.5 RPS6KB1 SWAP70 TBC1D12 TMEM133 TMEM52 WNT2B
Leg predicted mass (left) 2.38 34 19 57.6 -0.48 1.8e-03 ADM ARHGAP24 ARL3 CBX1 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FDFT1 FIBP FLJ33630 GATAD1 GLYR1 KIAA1199 KRIT1 MSRA MTERF NCOA1 NOV NT5C2 PMS2P3 PRELID1P1 RP11-332H18.4 RP11-436D10.3 RP11-6N17.4 S1PR2 SFXN2 SLC5A11 SLC9A3R2 SNX11 TMEM52 UPF3A USP36
Trunk fat mass 1.98 26 17 51.5 0.19 3.3e-01 ABHD17C ARL17A ARL17B CBX1 CDK6 CNNM2 CYP17A1-AS1 EDEM3 FIBP FNBP4 GPX1 KIAA1199 LOC100129961 MSRA OCIAD1 OLA1 PMS2P3 RERE RP11-296I10.6 RP11-6N17.4 SLC5A11 SLC9A3R2 SNX11 UPF3A USP36 WNT2B
Waist circumference 1.68 16 9 27.3 0.14 5.9e-01 ARL17A CBX1 CCDC148 CDK6 CYP17A1-AS1 FIBP FNBP4 KIAA1199 PMS2P3 RP11-296I10.6 RP11-6N17.4 SLC5A11 SLC9A3R2 SNX11 TMEM52 USP36
Number of incorrect matches in round 1.13 2 0 0.0 0.00 1.0e+00 CYP17A1-AS1 LOC100129961
Past tobacco smoking 1.63 6 1 3.0 -0.32 5.3e-01 ARL3 CYP17A1-AS1 INA NT5C2 SH2B3 SRR
Alcohol usually taken with meals 1.42 1 0 0.0 0.00 1.0e+00 SZT2
Nervous feelings 2.21 10 6 18.2 -0.25 4.6e-01 ADM ARL17B CNNM2 CYP17A1-AS1 FDFT1 FMNL1 LRRC37A4P MSRA NEK4 SRR
Frequency of tenseness / restlessness in last 2 weeks 1.92 5 3 9.1 -0.02 9.7e-01 ARL17B CNNM2 FMNL1 GPX1 LRRC37A4P
Hearing difficulty/problems with background noise 1.42 3 0 0.0 -1.00 2.1e-03 ARL17B LRRC37A4P UBL7
Hair/balding pattern: Pattern 2 1.97 5 5 15.2 -0.98 3.4e-04 ARL17B C4orf22 CPEB2 FMNL1 LRRC37A4P
Forced vital capacity (FVC) 2.97 23 16 48.5 -0.37 6.0e-02 ARL17A ARL17B CAMK1D CDK6 DCAF16 FLJ33630 FMNL1 GATAD1 GPX1 HOXB2 HOXB8 KIF24 LOC100129961 LRRC37A4P NCOA1 NOV RP11-541N10.3 RP11-6N17.6 RSRC1 SNX11 TMBIM1 U91328.21 UPF3A
Heel bone mineral density (BMD) T-score, automated (right) 2.28 10 7 21.2 0.78 4.4e-03 ARHGAP24 CDK6 DCAF16 FDFT1 GATAD1 KRIT1 MSRA RERE WNT2B ZNF827
Ever unenthusiastic/disinterested for a whole week 1.26 1 0 0.0 0.00 1.0e+00 LRRC37A4P
Qualifications: None of the above 1.45 4 2 6.1 0.99 1.2e-02 GPX1 IRAK1BP1 MPP6 SLC5A11
Mouth/teeth dental problems 1.55 1 0 0.0 0.00 1.0e+00 ARL17B
Heart attack 2.23 3 2 6.1 0.00 1.0e+00 FES NME6 RP1-257A7.5
Allergy 1.22 5 1 3.0 -0.52 3.7e-01 FES GCHFR LIME1 RERE TMBIM1
Diabetes (self-reported) 1.81 3 1 3.0 0.00 1.0e+00 CAMK1D RP1-239B22.5 ZBTB46
Medication: Ramipril 2.77 4 1 3.0 0.54 4.6e-01 FES GOPC TMEM133 UBL7
Medication: Simvastatin 2.24 2 2 6.1 0.00 1.0e+00 FES TCEA2
Fluid intelligence score 1.40 2 1 3.0 0.00 1.0e+00 ARL17B DCAF16
Illnesses of siblings 2.84 6 0 0.0 -0.96 2.5e-03 CLCN6 FES NME6 PRELID1P1 SH2B3 TMEM133
Neuroticism score 2.44 7 6 18.2 -0.62 1.0e-01 ADM ARL17B FDFT1 FMNL1 GPX1 LRRC37A4P MSRA
Weight 2.02 27 19 57.6 -0.20 2.7e-01 CBX1 CDK6 CNNM2 CYP17A1-AS1 DCAF16 FDFT1 FIBP GATAD1 GLYR1 GPX1 KIAA1199 KRIT1 MSRA OCIAD1 PMS2P3 RP11-296I10.6 RP11-332H18.4 RP11-436D10.3 RP11-6N17.4 SH2B3 SLC5A11 SLC9A3R2 SNX11 TMEM52 UPF3A USP36 WNT2B
Impedance of arm (right) 1.99 28 17 51.5 0.02 9.1e-01 ADM ARL17A ARL17B ARL3 CERS5 DCAF12 DCAKD EML1 FDFT1 FIBP FMNL1 GPX1 KIAA1199 KIF24 LIME1 LRRC37A4P MSRA NEK4 NOC3L PMS2P3 RP1-239B22.5 RPS6KB1 SENP3 SLC4A7 SLC9A3R2 TBC1D12 TMEM52 WNT2B
Arm fat percentage (right) 2.04 26 14 42.4 0.69 1.1e-04 ABHD17C ADM ARL17A CCDC148 CNNM2 DCAF16 EDEM3 FDFT1 FNBP4 GPX1 HOXB8 LOC100129961 MPP6 MSRA NCOA1 NOV OLA1 PMS2P3 RERE RP11-296I10.6 RP11-6N17.4 SENP3 SLC2A4 SLC5A11 SRR STXBP5
Trunk fat-free mass 2.77 36 27 81.8 -0.57 1.1e-04 ADM ARHGAP24 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FLJ33630 FMNL1 GATAD1 GLYR1 KIAA1199 KRIT1 LIME1 MTERF NCOA1 NOV OCIAD1 PRELID1P1 RP11-332H18.4 RP11-436D10.3 RP11-6N17.4 S1PR2 SENP3 SFXN2 SH2B3 SLC4A7 SLC5A11 SLC9A3R2 SNX11 TBC1D12 TMBIM1 TMEM133 TMEM52 UPF3A USP36
Hip circumference 1.92 23 13 39.4 -0.10 6.2e-01 CDK6 CLCN6 CNNM2 CYP17A1-AS1 DCAF16 FDFT1 FIBP GATAD1 GPX1 KIAA1199 LOC100129961 MSRA OLA1 PMS2P3 RP11-296I10.6 RP11-6N17.4 SH2B3 SLC5A11 SLC9A3R2 SNX11 TMEM52 UPF3A USP36
Time employed in main current job 1.33 1 0 0.0 0.00 1.0e+00 ARL17B
Father's age at death 1.64 3 2 6.1 0.00 1.0e+00 FES GPX1 SH2B3
Worrier / anxious feelings 2.32 8 7 21.2 -0.43 2.1e-01 ARL17B CNNM2 CYP17A1-AS1 FDFT1 FMNL1 LRRC37A4P MSRA NEK4
Frequency of tiredness / lethargy in last 2 weeks 1.21 2 0 0.0 0.00 1.0e+00 GPX1 PPP3CC
Hair/balding pattern: Pattern 3 2.56 5 4 12.1 0.97 1.2e-03 ARL17B C4orf22 DCAKD FMNL1 LRRC37A4P
Number of live births 1.48 1 0 0.0 0.00 1.0e+00 LRRC37A4P
Forced expiratory volume in 1-second (FEV1) 2.81 23 13 39.4 -0.25 2.3e-01 ARL17A ARL17B CAMK1D CDK6 DCAF16 FDFT1 FMNL1 GIT2 GOPC GPX1 HOXB2 HOXB8 LOC100129961 LRRC37A4P MSRA NCOA1 NOV RP11-541N10.3 RSRC1 TMBIM1 TMEM133 U91328.21 UPF3A
Pulse rate 1.60 1 1 3.0 0.00 1.0e+00 RBM23
Qualifications: A levels/AS levels or equivalent 1.56 5 2 6.1 -0.98 2.3e-03 DCAF16 GPX1 MPP6 MSRA PMS2P3
Mouth/teeth dental problems: Dentures 1.96 6 0 0.0 0.17 6.3e-01 CBX1 GPX1 MSRA RP11-6N17.6 RPS6KB1 SNX11
Asthma 1.14 2 1 3.0 0.00 1.0e+00 AC074212.6 RERE
Medication: Ibuprofen (e.g. Nurofen) 1.79 3 1 3.0 0.00 1.0e+00 FMNL1 LRRC37A4P RP1-257A7.5
Medication: Cholesterol lowering 2.14 3 2 6.1 0.00 1.0e+00 FES TCEA2 TMEM133
Illnesses of mother 2.45 1 1 3.0 0.00 1.0e+00 FES
Forced expiratory volume in 1-second (FEV1), Best measure 2.71 18 10 30.3 -0.28 2.4e-01 ARL17A ARL17B CAMK1D CDK6 DCAF16 FDFT1 FMNL1 GPX1 HOXB8 LOC100129961 LRRC37A4P MSRA NCOA1 RSRC1 S1PR2 TMEM133 U91328.21 UPF3A
Impedance of arm (left) 1.97 29 19 57.6 0.04 8.5e-01 ADM ARL17A ARL17B ARL3 CERS5 DCAF12 DCAKD FDFT1 FIBP FMNL1 GPX1 KIAA1199 KIF24 LIME1 LRRC37A4P MSRA NEK4 NOC3L PMS2P3 RP1-239B22.5 RPS6KB1 SENP3 SH2B3 SLC4A7 SLC9A3R2 TBC1D12 TMEM52 TNNT3 WNT2B
Arm fat mass (right) 1.86 25 10 30.3 0.36 7.3e-02 ABHD17C ARL17A CBX1 CDK6 CNNM2 CYP17A1-AS1 EDEM3 FDFT1 FIBP FNBP4 GPX1 KIAA1199 LOC100129961 MSRA OCIAD1 OLA1 PMS2P3 RP11-296I10.6 RP11-6N17.4 SLC5A11 SLC9A3R2 SNX11 STXBP5 TMEM52 USP36
Trunk predicted mass 2.77 34 27 81.8 -0.60 6.4e-05 ADM ARHGAP24 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FLJ33630 FMNL1 GATAD1 GLYR1 KIAA1199 KRIT1 LIME1 MTERF NCOA1 NOV PRELID1P1 RP11-332H18.4 RP11-436D10.3 RP11-6N17.4 S1PR2 SENP3 SFXN2 SH2B3 SLC4A7 SLC5A11 SLC9A3R2 SNX11 TBC1D12 TMBIM1 TMEM52 UPF3A USP36
Standing height 2.85 54 37 112.1 -0.49 5.0e-05 AC074212.6 ADM ARHGAP24 ARL17A ARL17B CDK6 CERS5 CFDP1 CLEC10A CMTR2 CYP17A1-AS1 DCAF16 DCAKD EDEM3 FDFT1 FGGY FLJ33630 GATAD1 GCHFR GLYR1 GOPC GPX1 GTF2B HOXB2 HOXB8 KRIT1 LRRC37A4P MGRN1 MPP6 MSRA MTERF NCOA1 NEK4 NOV OCIAD1 PPP3CC PRELID1P1 RP11-296I10.6 RP11-332H18.4 RP11-436D10.3 RP11-6N17.6 RP1-239B22.5 S1PR2 SFXN2 SH2B3 SLC5A11 SLC9A3R2 SNX11 TMBIM1 TRIM66 U91328.21 UPF3A USP36 WNT2B
Tense / 'highly strung' 1.89 6 1 3.0 -0.33 5.2e-01 ARL17B CNNM2 FDFT1 MSRA NT5C2 RERE
Seen doctor (GP) for nerves, anxiety, tension or depression 1.40 1 0 0.0 0.00 1.0e+00 SGIP1
Hair/balding pattern: Pattern 4 3.28 10 7 21.2 0.68 2.0e-02 ARL17B C4orf22 CERS5 CPEB2 DCAKD FMNL1 LRRC37A4P MKLN1-AS2 PRELID1P1 SRR
Birth weight of first child 2.73 9 5 15.2 -0.97 5.5e-07 CFDP1 CLCN6 DCAF16 FES GTF2B PMS2P3 SH2B3 TAS1R3 TBC1D12
Peak expiratory flow (PEF) 2.03 10 6 18.2 -0.17 6.3e-01 ARL17B CAMK1D CFDP1 DCAF16 FDFT1 GIT2 LRRC37A4P MSRA NCOA1 SLC9A3R2
Qualifications: O levels/GCSEs or equivalent 1.50 3 1 3.0 0.00 1.0e+00 GPX1 MPP6 RPS6KB1
Medication: Paracetamol 2.04 5 3 9.1 -0.31 5.5e-01 ARL17B GPX1 LRRC37A4P RP1-257A7.5 UFL1
Headache pain in last month 2.69 9 5 15.2 -0.41 2.3e-01 AC074212.6 ARL17B CFDP1 FMNL1 LRRC37A4P MED19 NEK4 RP1-257A7.5 UFL1
Medication for cholesterol, blood pressure or diabetes 4.01 15 8 24.2 -0.98 5.6e-12 ATP2B1 C4orf22 CAMK1D CLCN6 FES KIAA1199 NME6 RP11-588K22.2 SH2B3 SLC4A7 TCEA2 TMEM133 UBL7 UPF3A ZBTB46
Gout (self-reported) 1.45 2 0 0.0 0.00 1.0e+00 SH2B3 U91328.21
Hypothyroidism/myxoedema (self-reported) 1.67 4 2 6.1 -0.09 9.1e-01 FDFT1 MSRA RERE SH2B3
Medication: Amlodipine 3.91 8 5 15.2 0.98 7.2e-06 CLCN6 FES GLYR1 KIAA1199 SENP3 SLC4A7 TMEM133 TNNT3
Birth weight 2.48 9 6 18.2 -0.57 1.1e-01 CDK6 CNNM2 CYP17A1-AS1 DCAF16 FES S1PR2 SH2B3 SLC2A4 SRR
High blood pressure (siblings) 3.59 7 2 6.1 0.95 2.7e-04 CLCN6 FES PRELID1P1 SGIP1 SH2B3 TMEM133 TNNT3
Forced vital capacity (FVC), Best measure 2.86 21 14 42.4 -0.35 1.0e-01 ARL17A ARL17B CAMK1D CDK6 DCAF16 FLJ33630 FMNL1 GPX1 HOXB2 HOXB8 KIF24 LOC100129961 LRRC37A4P NCOA1 NOV RP11-6N17.6 RSRC1 SNX11 TMBIM1 U91328.21 UPF3A
Body fat percentage 2.15 30 13 39.4 0.73 3.7e-06 ABHD17C ADM ARL17A ARL17B CCDC148 DCAF16 DCAKD EDEM3 FIBP FMNL1 FNBP4 GPX1 LOC100129961 MPP6 MSRA NCOA1 NOC3L NOV OLA1 PMS2P3 RERE RP11-296I10.6 RP11-6N17.4 RP1-257A7.5 SENP3 SLC5A11 SLC9A3R2 STXBP5 TBC1D12 WNT2B
Leg fat percentage (right) 2.26 27 16 48.5 0.79 1.2e-06 ABHD17C ADM CCDC148 CRK DCAF16 EDEM3 FIBP FLJ33630 GPX1 GTF2B LOC100129961 MPP6 MSRA NCOA1 NOC3L NOV OLA1 PMS2P3 RERE RP11-296I10.6 RP11-6N17.4 SLC2A4 SLC5A11 SLC9A3R2 STXBP5 TBC1D12 WNT2B
Arm fat-free mass (right) 2.40 33 23 69.7 -0.47 3.5e-03 ADM ARHGAP24 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FDFT1 FIBP FMNL1 GATAD1 GLYR1 GPX1 KIAA1199 KRIT1 LIME1 MSRA NCOA1 NOV PRELID1P1 RP11-332H18.4 RP11-6N17.4 S1PR2 SENP3 SFXN2 SH2B3 SLC5A11 SLC9A3R2 SNX11 TMBIM1 TMEM52 UPF3A USP36
Comparative body size at age 10 1.75 10 6 18.2 -0.14 7.1e-01 AQP5 CAMK1G CERS5 FDFT1 MSRA NCOA1 SRR TMEM52 VGLL4 WNT2B
Number of full brothers 1.15 1 0 0.0 0.00 1.0e+00 ARL17B
Worry too long after embarrassment 1.74 4 3 9.1 -0.98 2.7e-03 ARL17B FDFT1 LRRC37A4P MSRA
Wheeze or whistling in the chest in last year 1.19 2 0 0.0 0.00 1.0e+00 AC074212.6 DCAKD
Age at first live birth 1.40 2 1 3.0 0.00 1.0e+00 DCAF16 GPX1
Pulse wave peak to peak time 1.64 1 0 0.0 0.00 1.0e+00 CYP17A1-AS1
Shortness of breath walking on level ground 1.27 2 0 0.0 0.00 1.0e+00 SGIP1 USP36
Qualifications: College or University degree 1.59 11 4 12.1 -0.51 9.4e-02 ARL17B CCDC148 DCAF16 EDEM3 GPX1 GTF2B HAUS4 LRRC37A4P MPP6 PMS2P3 SLC5A11
Emphysema/chronic bronchitis 1.40 1 0 0.0 0.00 1.0e+00 ARL17B
Medication for pain relief, constipation, heartburn 1.86 5 2 6.1 -0.36 4.9e-01 GPX1 KIAA1199 LRRC37A4P RP1-257A7.5 UFL1
Neck or shoulder pain in last month 1.25 1 0 0.0 0.00 1.0e+00 GPX1
Medication: Blood pressure 5.20 21 13 39.4 0.98 3.2e-16 ATP2B1 C4orf22 CLCN6 CWF19L2 DCAF16 FES FNBP4 HOXB2 KIAA1199 NME6 NOC3L PRELID1P1 SENP3 SH2B3 SLC2A4 SLC4A7 TMEM133 TNNT3 UBL7 UPF3A ZBTB46
Angina (self-reported) 2.27 3 1 3.0 0.00 1.0e+00 FES RP1-257A7.5 TCEA2
Migraine (self-reported) 2.26 5 1 3.0 -0.26 6.7e-01 ARL3 NT5C2 RP1-257A7.5 SFXN2 UFL1
Medication: Ibuprofen 1.60 1 0 0.0 0.00 1.0e+00 RP1-257A7.5
Mean time to correctly identify matches 1.75 4 3 9.1 0.13 8.7e-01 ARL17A ARL17B OLA1 SH2B3
Whole body fat mass 1.92 29 13 39.4 0.32 8.5e-02 ABHD17C ARL17A CBX1 CCDC148 CDK6 CNNM2 CYP17A1-AS1 EDEM3 FDFT1 FIBP FNBP4 GPX1 KIAA1199 LOC100129961 MPP6 MSRA OCIAD1 OLA1 PMS2P3 RERE RP11-296I10.6 RP11-6N17.4 SLC5A11 SLC9A3R2 SNX11 STXBP5 UPF3A USP36 WNT2B
Leg fat mass (right) 1.93 23 10 30.3 0.47 2.4e-02 ABHD17C CDK6 CNNM2 CYP17A1-AS1 EDEM3 FDFT1 FIBP GPX1 KIAA1199 LOC100129961 MPP6 MSRA OLA1 PMS2P3 RERE RP11-296I10.6 RP11-6N17.4 SLC5A11 SLC9A3R2 STXBP5 TMEM52 USP36 WNT2B
Arm predicted mass (right) 2.45 35 22 66.7 -0.45 4.8e-03 ADM ARHGAP24 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FDFT1 FIBP FMNL1 GATAD1 GLYR1 GPX1 KIAA1199 KRIT1 LIME1 MSRA MTERF NCOA1 NOV PRELID1P1 RP11-332H18.4 RP11-6N17.4 S1PR2 SENP3 SFXN2 SH2B3 SLC4A7 SLC5A11 SLC9A3R2 SNX11 TMBIM1 TMEM52 UPF3A USP36
Pulse rate, automated reading 1.47 7 2 6.1 -0.05 9.2e-01 FNBP4 LOC100129961 MKLN1-AS2 NEK4 PMS2P3 RBM23 SZT2
Alcohol intake frequency. 1.46 6 1 3.0 -0.21 6.5e-01 ARL17B FIBP FNBP4 LRRC37A4P RP1-257A7.5 RPS6KB1
Comparative height size at age 10 2.54 32 22 66.7 -0.45 6.1e-03 ARL17B CDK6 CFDP1 CYP17A1-AS1 DCAF16 GATAD1 GLYR1 GPX1 GTF2B HOXB8 KIAA1199 KRIT1 LRRC37A4P NCOA1 NEK4 NOV OCIAD1 PRELID1P1 RP11-332H18.4 RP11-6N17.6 RP1-239B22.5 S1PR2 SFXN2 SH2B3 SLC9A3R2 SNX11 SZT2 TMBIM1 U91328.21 UPF3A USP36 WNT2B
Suffer from 'nerves' 1.69 4 0 0.0 -0.98 1.8e-02 ARL17B FDFT1 MSRA RERE
Overall health rating 1.63 6 2 6.1 0.96 2.9e-03 CEP68 DCAKD GPX1 MSRA SLC5A11 VGLL4
Chest pain or discomfort 1.28 1 0 0.0 0.00 1.0e+00 USP36
Age at last live birth 1.44 1 1 3.0 0.00 1.0e+00 GPX1
Medication: Aspirin 2.18 2 1 3.0 0.00 1.0e+00 FES GOPC
Hypertension (Self-reported) 8.03 79 45 136.4 0.98 8.7e-58 AC006111.1 ADM AGT AQP5 ARHGAP24 ARL17A ARL3 ATP2B1 ATP8B3 C4orf22 CCDC148 CERS5 CFDP1 CLCN6 CLEC10A CMTR2 CNNM2 CWF19L2 DCAF12 DCAF16 DCAKD EDEM3 FDFT1 FES FIBP FLJ33630 FMNL1 FNBP4 GCHFR GIT2 GLYR1 GOPC GTF2B HOXB2 HOXB8 IRAK1BP1 ITGB5 KIAA1199 LIME1 LRRC37A4P MARK2 MGRN1 MSRA NCOA1 NEIL2 NME6 NOC3L NSUN6 NT5C2 PLEKHM2 PMS2P3 PRELID1P1 RP11-296I10.6 RP11-332H18.4 RP11-436D10.3 RP11-588K22.2 RP11-790I12.2 RP1-239B22.5 RSRC1 S1PR2 SENP3 SFXN2 SH2B3 SLC2A4 SLC4A7 SLC5A11 SRR SWAP70 TBC1D12 TCEA2 TMEM133 TNNT3 U91328.21 UBL7 UFL1 UPF3A VGLL4 WNT2B ZBTB46
Gastro-oesophageal reflux (gord) / gastric reflux (Self-reported) 1.38 2 0 0.0 0.00 1.0e+00 FMNL1 MARK2
Illnesses of father: Heart disease 2.06 2 2 6.1 0.00 1.0e+00 FES RP1-257A7.5
Illnesses of siblings: Diabetes 1.69 1 1 3.0 0.00 1.0e+00 CAMK1D
Smoking status: Previous 1.26 1 0 0.0 0.00 1.0e+00 SH2B3
Forced expiratory volume in 1-second (FEV1), predicted 2.23 4 2 6.1 -0.71 1.8e-01 CDK6 CYP17A1-AS1 DCAF16 NCOA1
Whole body fat-free mass 2.63 39 25 75.8 -0.54 1.6e-04 ADM ARHGAP24 ARL3 CBX1 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FDFT1 FIBP FLJ33630 FMNL1 GATAD1 GLYR1 KIAA1199 KRIT1 MSRA MTERF NCOA1 NOV NT5C2 PRELID1P1 RP11-332H18.4 RP11-436D10.3 RP11-6N17.4 S1PR2 SENP3 SFXN2 SH2B3 SLC4A7 SLC5A11 SLC9A3R2 SNX11 TBC1D12 TMBIM1 TMEM52 UPF3A USP36
Leg fat-free mass (right) 2.39 35 19 57.6 -0.49 1.8e-03 ADM ARHGAP24 ARL3 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FDFT1 FES FIBP FLJ33630 GATAD1 GLYR1 KIAA1199 KRIT1 MSRA NCOA1 NOV NT5C2 PMS2P3 PRELID1P1 RP11-332H18.4 RP11-436D10.3 RP11-6N17.4 S1PR2 SFXN2 SH2B3 SLC5A11 SLC9A3R2 SNX11 TBC1D12 TMEM52 UPF3A USP36
Arm fat percentage (left) 2.01 27 13 39.4 0.69 7.1e-05 ABHD17C ADM ARL17A CCDC148 CNNM2 DCAF16 EDEM3 FDFT1 FIBP FNBP4 GPX1 HOXB8 LOC100129961 MPP6 MSRA NCOA1 NOV OLA1 PMS2P3 RERE RP11-296I10.6 RP11-6N17.4 RP1-257A7.5 SENP3 SLC5A11 SRR STXBP5
Handedness (chirality/laterality): Left-handed 1.83 2 2 6.1 0.00 1.0e+00 ARL17B LRRC37A4P
Mood swings 1.90 6 5 15.2 -0.36 4.2e-01 ARL17B FMNL1 GPX1 LRRC37A4P MSRA SLC5A11
Loneliness, isolation 1.64 2 1 3.0 0.00 1.0e+00 GPX1 LRRC37A4P
Diabetes diagnosed by doctor 1.92 3 3 9.1 0.00 1.0e+00 CAMK1D RP1-239B22.5 ZBTB46
Mouth/teeth dental problems: Mouth ulcers 1.62 4 2 6.1 -0.74 1.5e-01 ARL17B ITGB3 LRRC37A4P TRIM59
Medication for cholesterol 4.19 12 4 12.1 -0.96 5.4e-07 AGT C4orf22 FES LIME1 LRRC37A4P MGRN1 PRELID1P1 SH2B3 TMEM133 TNNT3 WNT2B ZBTB46
Breast cancer (self-reported) 1.15 1 1 3.0 0.00 1.0e+00 SLC4A7
Asthma (self-reported) 1.07 3 1 3.0 0.00 1.0e+00 AC074212.6 RERE UFL1
Medication: Aspirin 2.10 1 1 3.0 0.00 1.0e+00 FES
Illnesses of father: None of the above (group 1) 2.73 3 1 3.0 0.00 1.0e+00 CYP17A1-AS1 FES SH2B3
Smoking status: Current 1.62 2 0 0.0 0.00 1.0e+00 MSRA SRR
Forced expiratory volume in 1-second (FEV1), predicted percentage 2.07 7 6 18.2 -0.22 6.1e-01 ARL17B CAMK1D CFDP1 FDFT1 FMNL1 LRRC37A4P RP11-541N10.3
Whole body water mass 2.61 39 25 75.8 -0.51 4.1e-04 ADM ARHGAP24 ARL3 CBX1 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FDFT1 FIBP FLJ33630 FMNL1 GATAD1 GLYR1 KIAA1199 KRIT1 MSRA MTERF NCOA1 NOV NT5C2 OCIAD1 PRELID1P1 RP11-332H18.4 RP11-436D10.3 RP11-6N17.4 S1PR2 SFXN2 SH2B3 SLC4A7 SLC5A11 SLC9A3R2 SNX11 TBC1D12 TMBIM1 TMEM52 UPF3A USP36
Leg predicted mass (right) 2.39 34 20 60.6 -0.48 2.4e-03 ADM ARHGAP24 ARL3 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FDFT1 FES FIBP FLJ33630 GATAD1 GLYR1 KIAA1199 KRIT1 MSRA NCOA1 NOV NT5C2 PMS2P3 PRELID1P1 RP11-332H18.4 RP11-436D10.3 RP11-6N17.4 S1PR2 SFXN2 SLC5A11 SLC9A3R2 SNX11 TBC1D12 TMEM52 UPF3A USP36
Arm fat mass (left) 1.80 25 11 33.3 0.37 7.2e-02 ABHD17C ARL17A CBX1 CCDC148 CDK6 CNNM2 CYP17A1-AS1 EDEM3 FDFT1 FIBP FNBP4 GPX1 KIAA1199 LOC100129961 MSRA OLA1 PMS2P3 RP11-296I10.6 RP11-6N17.4 SLC5A11 SLC9A3R2 SNX11 STXBP5 TMEM52 USP36
Number of self-reported non-cancer illnesses 2.55 3 1 3.0 0.00 1.0e+00 CLCN6 SH2B3 TCEA2
Average weekly champagne plus white wine intake 1.59 1 0 0.0 0.00 1.0e+00 LRRC37A4P
Miserableness 1.65 6 3 9.1 -0.29 5.2e-01 ARL17B FDFT1 FNBP4 GPX1 LRRC37A4P MSRA
Guilty feelings 1.85 5 1 3.0 -0.31 5.5e-01 FDFT1 FNBP4 LRRC37A4P MSRA UBXN2A
Mother's age at death 1.29 1 0 0.0 0.00 1.0e+00 CLCN6
Financial situation satisfaction 1.06 1 1 3.0 0.00 1.0e+00 GPX1
Medication: Blood pressure 6.35 31 21 63.6 0.98 6.3e-24 ADM AGT AQP5 C4orf22 CERS5 CLCN6 CNNM2 CWF19L2 FDFT1 FES FMNL1 GTF2B KIAA1199 LIME1 LRRC37A4P MGRN1 MSRA NME6 NT5C2 PRELID1P1 RP11-436D10.3 RP11-588K22.2 SENP3 SH2B3 SLC4A7 TCEA2 TMEM133 TNNT3 UBL7 WNT2B ZBTB46
Supplements: Fish oil (including cod liver oil) 1.10 1 0 0.0 0.00 1.0e+00 DCAKD
High cholesterol (Self-reported) 2.18 4 2 6.1 0.93 7.0e-02 DCAF16 TCEA2 TMBIM1 TMEM133
Medication: Bendroflumethiazide 4.36 13 5 15.2 0.97 4.2e-08 ATP2B1 FES FNBP4 KIAA1199 MGRN1 MSRA PRELID1P1 RP11-436D10.3 SH2B3 SLC4A7 TMEM133 TNNT3 UBL7
Medication: Paracetamol 1.96 4 2 6.1 -0.11 8.6e-01 ARL17B GPX1 LRRC37A4P UFL1
Illnesses of father: High blood pressure 3.11 3 1 3.0 0.00 1.0e+00 C4orf22 FES UPF3A
Ever smoked 1.55 4 0 0.0 -0.16 8.4e-01 ARL3 CYP17A1-AS1 NT5C2 SRR
Basal metabolic rate 2.45 38 28 84.8 -0.45 2.4e-03 ADM ARHGAP24 ARL3 CBX1 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FDFT1 FIBP FLJ33630 GATAD1 GLYR1 GPX1 KIAA1199 KRIT1 MSRA MTERF NCOA1 NOV NT5C2 OCIAD1 PMS2P3 PRELID1P1 RP11-332H18.4 RP11-436D10.3 RP11-6N17.4 S1PR2 SFXN2 SH2B3 SLC5A11 SLC9A3R2 SNX11 TMBIM1 TMEM52 UPF3A USP36
Leg fat percentage (left) 2.23 25 16 48.5 0.77 6.7e-06 ABHD17C ADM CCDC148 CRK DCAF16 EDEM3 FIBP FLJ33630 GPX1 GTF2B HOXB8 LOC100129961 MPP6 MSRA NCOA1 NOV PMS2P3 RERE RP11-296I10.6 RP11-6N17.4 SLC2A4 SLC5A11 SLC9A3R2 TBC1D12 WNT2B
Arm fat-free mass (left) 2.45 35 24 72.7 -0.43 6.1e-03 ADM ARHGAP24 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FDFT1 FIBP FMNL1 GATAD1 GLYR1 GPX1 KIAA1199 KRIT1 LIME1 MSRA NCOA1 NOV OCIAD1 PRELID1P1 RP11-332H18.4 RP11-6N17.4 S1PR2 SENP3 SFXN2 SH2B3 SLC4A7 SLC5A11 SLC9A3R2 SNX11 TMBIM1 TMEM52 UPF3A USP36
Number of operations (self-reported) 1.32 1 0 0.0 0.00 1.0e+00 GPX1
Average weekly beer plus cider intake 1.20 2 0 0.0 0.00 1.0e+00 AQP5 FDFT1
Irritability 1.95 5 4 12.1 -0.74 9.2e-02 ARL17B FDFT1 GPX1 LRRC37A4P MSRA
Risk taking 1.49 2 1 3.0 0.00 1.0e+00 MSRA MTERF
Diastolic blood pressure, automated reading 7.71 73 53 160.6 0.91 2.1e-30 AC006111.1 ADAMTS8 ADM AGT AQP5 ARHGAP24 ARL17A ATP2B1 C4orf22 CCDC148 CERS5 CLCN6 CNNM2 CWF19L2 DCAF12 DCAF16 DCAKD DNAJC12 EDEM3 EIF2AK4 FDFT1 FES FIBP FMNL1 FNBP4 GCHFR GPX1 HAUS4 INA IRAK1BP1 ITGB5 KIAA1199 LIME1 LOC100129961 MED19 MKLN1-AS2 MPP6 MSRA NCAM1-AS1 NCOA1 NEIL2 NME6 NOC3L NOV NSUN6 NT5C2 PMS2P3 PRELID1P1 RABL2A RERE RP11-332H18.4 RP11-436D10.3 RSRC1 SENP3 SH2B3 SLC16A1 SLC2A4 SLC5A11 SLC9A3R2 SRR STXBP5 SWAP70 SZT2 TCEA2 TEX2 TMEM133 TNNT3 TRIM66 UBL7 ULK4 UPF3A USP36 WNT2B
Vascular/heart problems diagnosed by doctor 7.82 69 39 118.2 -0.98 2.5e-51 AC006111.1 AGT AQP5 ARHGAP24 ARL3 ATP2B1 C4orf22 CCDC148 CEP68 CERS5 CFDP1 CLCN6 CNNM2 CWF19L2 DCAF16 DCAKD EDEM3 FDFT1 FES FIBP FLJ33630 FMNL1 FNBP4 GCHFR GIT2 GLYR1 GOPC GTF2B HOXB2 HOXB8 INA IRAK1BP1 ITGB5 KIAA1199 LIME1 MARK2 MGRN1 MSRA NEIL2 NME6 NOC3L NSUN6 NT5C2 OLA1 PLEKHM2 PRELID1P1 RP11-436D10.3 RP11-588K22.2 RP11-790I12.2 RSRC1 S1PR2 SENP3 SGIP1 SH2B3 SLC2A4 SLC4A7 SLC5A11 SRR SWAP70 SZT2 TBC1D12 TCEA2 TEX2 TMEM133 TNNT3 UBL7 VGLL4 WNT2B ZBTB46
Cholesterol lowering medication 2.21 4 0 0.0 1.00 6.2e-04 COL21A1 DCAF16 MARK2 TCEA2
Pain experienced in last month 1.48 3 1 3.0 0.00 1.0e+00 ARL17B GPX1 UFL1
Heart attack/myocardial infarction (self-reported) 2.19 4 2 6.1 0.52 4.8e-01 FES NME6 RP1-257A7.5 SH2B3
Heart disease (siblings) 1.95 1 0 0.0 0.00 1.0e+00 FES
Pack years of smoking 1.18 1 0 0.0 0.00 1.0e+00 GPX1
Impedance of whole body 2.15 31 26 78.8 0.12 5.3e-01 ADM ARL17A ARL17B ARL3 CERS5 CNNM2 DCAF12 DCAKD FDFT1 FIBP FLJ33630 FMNL1 GPX1 KIAA1199 KIF24 LIME1 LRRC37A4P MSRA NEK4 NOC3L NT5C2 PMS2P3 RP11-296I10.6 RP1-239B22.5 RPS6KB1 SENP3 SLC4A7 SWAP70 TBC1D12 TMEM52 WNT2B
Leg fat mass (left) 1.92 23 11 33.3 0.47 2.2e-02 ABHD17C CDK6 CNNM2 CYP17A1-AS1 EDEM3 FDFT1 FIBP GPX1 KIAA1199 LOC100129961 MPP6 MSRA OLA1 PMS2P3 RERE RP11-296I10.6 RP11-6N17.4 SLC5A11 SLC9A3R2 STXBP5 TMEM52 USP36 WNT2B
Arm predicted mass (left) 2.45 33 23 69.7 -0.44 5.2e-03 ADM ARHGAP24 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FDFT1 FIBP GATAD1 GLYR1 GPX1 KIAA1199 KRIT1 LIME1 MSRA NCOA1 NOV PRELID1P1 RP11-332H18.4 RP11-6N17.4 S1PR2 SENP3 SFXN2 SH2B3 SLC4A7 SLC5A11 SLC9A3R2 SNX11 TMBIM1 TMEM52 UPF3A USP36

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 45 1.289 3.05
GTEx Adipose Visceral Omentum 33 1.621 3.21
GTEx Adrenal Gland 21 1.441 2.96
GTEx Artery Aorta 54 1.814 3.38
GTEx Artery Coronary 20 1.691 3.33
GTEx Artery Tibial 56 1.489 3.29
GTEx Brain Caudate basal ganglia 10 1.087 3.14
GTEx Brain Cerebellar Hemisphere 24 1.612 3.17
GTEx Brain Cerebellum 32 1.615 3.24
GTEx Brain Cortex 16 1.546 3.13
GTEx Brain Frontal Cortex BA9 19 2.056 3.39
GTEx Brain Hippocampus 5 0.954 3.00
GTEx Brain Hypothalamus 6 1.017 2.92
GTEx Brain Nucleus accumbens basal ganglia 13 1.503 3.03
GTEx Brain Putamen basal ganglia 8 1.282 3.02
GTEx Breast Mammary Tissue 36 1.824 3.05
GTEx Breast Mammary Tissue (Male) 14 1.174 3.10
GTEx Breast Mammary Tissue (Female) 21 1.277 3.00
GTEx Cells EBV-transformed lymphocytes 21 1.476 3.19
GTEx Cells Transformed fibroblasts 49 1.167 2.93
GTEx Colon Sigmoid 24 1.642 3.22
GTEx Colon Transverse 30 1.453 3.03
GTEx Esophagus Gastroesophageal Junction 32 2.215 3.37
GTEx Esophagus Mucosa 39 1.175 2.99
GTEx Esophagus Muscularis 42 1.300 3.03
GTEx Heart Atrial Appendage 20 1.267 3.02
GTEx Heart Left Ventricle 18 1.176 3.09
GTEx Liver 9 1.255 2.90
GTEx Lung 40 1.392 3.01
GTEx Muscle Skeletal 34 1.176 3.13
GTEx Nerve Tibial 51 1.180 2.86
GTEx Ovary 19 2.093 3.21
GTEx Pancreas 28 1.716 3.16
GTEx Pituitary 14 1.256 3.05
GTEx Prostate 15 1.796 3.35
GTEx Skin Not Sun Exposed Suprapubic 31 1.261 3.09
GTEx Skin Sun Exposed Lower leg 48 1.319 3.00
GTEx Small Intestine Terminal Ileum 8 1.735 3.16
GTEx Spleen 17 1.205 3.10
GTEx Stomach 29 1.994 3.46
GTEx Testis 45 1.426 3.03
GTEx Thyroid 54 1.350 2.89
GTEx Uterus 10 1.764 2.83
GTEx Vagina 9 1.417 3.24
GTEx Whole Blood 22 1.104 2.91
METSIM Adipose 32 0.694 2.56
NTR Blood 23 0.958 2.78
ROSMAP Brain Pre-frontal Cortex 54 1.230 3.10
YFS Blood 36 0.780 2.64
CommonMind Brain Pre-frontal Cortex 65 1.209 2.82
TCGA Breast Tumor 10 1.304 2.95
TCGA Breast Normal 44 1.046 2.61
TCGA Ovarian Tumor 20 0.684 2.51
TCGA Prostate Tumor 38 1.099 2.71